Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 366

1.

Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study.

Kaltenbach B, Franke J, Bertog SC, Steinberg DH, Hofmann I, Sievert H.

Catheter Cardiovasc Interv. 2013 Feb;81(2):335-9. doi: 10.1002/ccd.24557. Epub 2012 Aug 13.

PMID:
22807098
[PubMed - indexed for MEDLINE]
2.

Renal denervation in moderate treatment-resistant hypertension.

Ott C, Mahfoud F, Schmid A, Ditting T, Sobotka PA, Veelken R, Spies A, Ukena C, Laufs U, Uder M, Böhm M, Schmieder RE.

J Am Coll Cardiol. 2013 Nov 12;62(20):1880-6. doi: 10.1016/j.jacc.2013.06.023. Epub 2013 Jul 10.

PMID:
23850901
[PubMed - indexed for MEDLINE]
Free Article
3.

Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter.

Prochnau D, Lucas N, Kuehnert H, Figulla HR, Surber R.

EuroIntervention. 2012 Jan;7(9):1077-80. doi: 10.4244/EIJV7I9A171.

PMID:
21959556
[PubMed - indexed for MEDLINE]
Free Article
4.

Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension.

Fadl Elmula FE, Hoffmann P, Larstorp AC, Fossum E, Brekke M, Kjeldsen SE, Gjønnæss E, Hjørnholm U, Kjaer VN, Rostrup M, Os I, Stenehjem A, Høieggen A.

Hypertension. 2014 May;63(5):991-9. doi: 10.1161/HYPERTENSIONAHA.114.03246. Epub 2014 Mar 3.

PMID:
24591332
[PubMed - indexed for MEDLINE]
5.

Catheter-based renal denervation for resistant hypertension: 12-month results of the EnligHTN I first-in-human study using a multielectrode ablation system.

Papademetriou V, Tsioufis CP, Sinhal A, Chew DP, Meredith IT, Malaiapan Y, Worthley MI, Worthley SG.

Hypertension. 2014 Sep;64(3):565-72. doi: 10.1161/HYPERTENSIONAHA.114.03605. Epub 2014 Jun 16.

PMID:
24935940
[PubMed - indexed for MEDLINE]
6.

Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial.

Symplicity HTN-2 Investigators, Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Böhm M.

Lancet. 2010 Dec 4;376(9756):1903-9. doi: 10.1016/S0140-6736(10)62039-9. Epub 2010 Nov 17.

PMID:
21093036
[PubMed - indexed for MEDLINE]
7.

Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study.

Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham WT, Esler M.

Lancet. 2009 Apr 11;373(9671):1275-81. doi: 10.1016/S0140-6736(09)60566-3. Epub 2009 Mar 28.

PMID:
19332353
[PubMed - indexed for MEDLINE]
8.

Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months.

Symplicity HTN-1 Investigators.

Hypertension. 2011 May;57(5):911-7. doi: 10.1161/HYPERTENSIONAHA.110.163014. Epub 2011 Mar 14.

PMID:
21403086
[PubMed - indexed for MEDLINE]
Free Article
9.

Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension.

Mahfoud F, Ukena C, Schmieder RE, Cremers B, Rump LC, Vonend O, Weil J, Schmidt M, Hoppe UC, Zeller T, Bauer A, Ott C, Blessing E, Sobotka PA, Krum H, Schlaich M, Esler M, Böhm M.

Circulation. 2013 Jul 9;128(2):132-40. doi: 10.1161/CIRCULATIONAHA.112.000949. Epub 2013 Jun 18. Erratum in: Circulation. 2014 May 20;129(20):e502.

PMID:
23780578
[PubMed - indexed for MEDLINE]
Free Article
10.

Renal sympathetic denervation therapy in the real world: results from the Heidelberg registry.

Vogel B, Kirchberger M, Zeier M, Stoll F, Meder B, Saure D, Andrassy M, Mueller OJ, Hardt S, Schwenger V, Strothmeyer A, Katus HA, Blessing E.

Clin Res Cardiol. 2014 Feb;103(2):117-24. doi: 10.1007/s00392-013-0627-5. Epub 2013 Oct 15.

PMID:
24126436
[PubMed - indexed for MEDLINE]
11.

Renal sympathetic denervation in patients with treatment-resistant hypertension after witnessed intake of medication before qualifying ambulatory blood pressure.

Fadl Elmula FE, Hoffmann P, Fossum E, Brekke M, Gjønnæss E, Hjørnholm U, Kjær VN, Rostrup M, Kjeldsen SE, Os I, Stenehjem AE, Høieggen A.

Hypertension. 2013 Sep;62(3):526-32. doi: 10.1161/HYPERTENSIONAHA.113.01452. Epub 2013 Jul 8.

PMID:
23836798
[PubMed - indexed for MEDLINE]
Free Article
12.

Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial.

Worthley SG, Tsioufis CP, Worthley MI, Sinhal A, Chew DP, Meredith IT, Malaiapan Y, Papademetriou V.

Eur Heart J. 2013 Jul;34(28):2132-40. doi: 10.1093/eurheartj/eht197. Epub 2013 Jun 19.

PMID:
23782649
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea.

Witkowski A, Prejbisz A, Florczak E, Kądziela J, Śliwiński P, Bieleń P, Michałowska I, Kabat M, Warchoł E, Januszewicz M, Narkiewicz K, Somers VK, Sobotka PA, Januszewicz A.

Hypertension. 2011 Oct;58(4):559-65. doi: 10.1161/HYPERTENSIONAHA.111.173799. Epub 2011 Aug 15.

PMID:
21844482
[PubMed - indexed for MEDLINE]
Free Article
14.

Vascular and renal hemodynamic changes after renal denervation.

Ott C, Janka R, Schmid A, Titze S, Ditting T, Sobotka PA, Veelken R, Uder M, Schmieder RE.

Clin J Am Soc Nephrol. 2013 Jul;8(7):1195-201. doi: 10.2215/CJN.08500812. Epub 2013 Apr 4.

PMID:
23559677
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study.

Mahfoud F, Schlaich M, Kindermann I, Ukena C, Cremers B, Brandt MC, Hoppe UC, Vonend O, Rump LC, Sobotka PA, Krum H, Esler M, Böhm M.

Circulation. 2011 May 10;123(18):1940-6. doi: 10.1161/CIRCULATIONAHA.110.991869. Epub 2011 Apr 25.

PMID:
21518978
[PubMed - indexed for MEDLINE]
Free Article
16.

Renal denervation using an irrigated catheter in patients with resistant hypertension: a promising strategy?

Armaganijan L, Staico R, Moraes A, Abizaid A, Moreira D, Amodeo C, Sousa M, Borelli F, Armaganijan D, Sousa JE, Sousa A.

Arq Bras Cardiol. 2014 Apr;102(4):355-63. doi: 10.5935/abc.20140034. Epub 2014 Feb 17. English, Portuguese.

PMID:
24652055
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Effects of renal denervation with a standard irrigated cardiac ablation catheter on blood pressure and renal function in patients with chronic kidney disease and resistant hypertension.

Kiuchi MG, Maia GL, de Queiroz Carreira MA, Kiuchi T, Chen S, Andrea BR, Graciano ML, Lugon JR.

Eur Heart J. 2013 Jul;34(28):2114-21. doi: 10.1093/eurheartj/eht200. Epub 2013 Jun 20.

PMID:
23786861
[PubMed - indexed for MEDLINE]
Free Article
18.

Sustained sympathetic and blood pressure reduction 1 year after renal denervation in patients with resistant hypertension.

Hering D, Marusic P, Walton AS, Lambert EA, Krum H, Narkiewicz K, Lambert GW, Esler MD, Schlaich MP.

Hypertension. 2014 Jul;64(1):118-24. doi: 10.1161/HYPERTENSIONAHA.113.03098. Epub 2014 Apr 14.

PMID:
24732891
[PubMed - indexed for MEDLINE]
19.

[Safety and short-term efficacy of renal sympathetic denervation in the treatment of resistant hypertension].

Jiang XJ, Liang T, Dong H, Peng M, Ma WJ, Guan T, Zhang HM, Bian J, Xu B, Gao RL.

Zhonghua Yi Xue Za Zhi. 2012 Dec 11;92(46):3265-8. Chinese.

PMID:
23328511
[PubMed - indexed for MEDLINE]
20.

Expert consensus: renal denervation for the treatment of arterial hypertension.

Pathak A, Girerd X, Azizi M, Benamer H, Halimi JM, Lantelme P, Lefèvre T, Sapoval M; French Society of Hypertension; French Society of Cardiology; Working Group on Atheroma, Interventional Cardiology; French Society of Radiology.

Arch Cardiovasc Dis. 2012 Jun-Jul;105(6-7):386-93. Review.

PMID:
22977923
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk